COVID-19 in multiple sclerosis patients and risk factors for severe infection

Multiple sclerosis (MS) patients have been considered a higher-risk population for COVID-19 due to the high prevalence of disability and disease-modifying therapy use; however, there is little data identifying clinical characteristics of MS associated with worse COVID-19 outcomes. Therefore, we cond...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Neurol Sci
Hlavní autoři: Chaudhry, Farhan, Bulka, Helena, Rathnam, Anirudha S., Said, Omar M., Lin, Jia, Lorigan, Holly, Bernitsas, Eva, Rube, Jacob, Korzeniewski, Steven J., Memon, Anza B., Levy, Phillip D., Schultz, Lonni, Javed, Adil, Lisak, Robert, Cerghet, Mirela
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier B.V. 2020
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7834402/
https://ncbi.nlm.nih.gov/pubmed/32980780
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jns.2020.117147
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky